| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |